BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Apidra® cartridges (insulin glulisine [produced by recombinant DNA technology]): Shortage of Apidra®

2011.09.26

Active substance: insulin glulisine

Information on a temporary shortage in the supply of Apidra 3 ml cartridges. In Germany, this concerns the following products: Apidra® cartridge, Apidra® cartridge for OptiClik®, Apidra® SoloStar®, Apidra® OptiSet®. A Rote-Hand-Brief will be circulated.

Additional information (available in German only):

Apidra® - wichtige Patienteninformation zur Umstellung auf kurzwirksames Humaninsulin PDF, 21KB, File is accessible

Apidra® - wichtige Patienteninformation zur Umstellung auf andere schnellwirksame Analoginsuline PDF, 25KB, File is accessible

Apidra® - wichtige Information für die Fachkreise PDF, 33KB, File is accessible

Anleitung zur Handhabung von Durchstechflasche und Einmalspritze PDF, 77KB, File is accessible

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 81KB, File is accessible